03.07.2025 • NewsSolvayinvestment

Solvay Joint Venture Invests in Production Unit in Chile

Peróxidos do Brasil, a joint venture between Solvay and Produtos Químicos Makay (PQM), announces a new strategic investment in its production unit in Chile, reaffirming its commitment to excellence in supply for customers across various markets in South America.

Production unit in Chile
Located in the Coronel Industrial Park, in the BioBío region, Peróxidos’ plant in Chile is the only industrial unit for hydrogen peroxide production on the Pacific Coast.
© Solvay

A $12 million (€10.2 million) investment will fund the installation of a new production section, enabling the unit to expand its product portfolio and better serve all segments of the Andean market. This strategic initiative strengthens Peróxidos’ commitment to sustainability by supporting the gradual reduction of CO₂ emissions in its manufacturing processes. With all permits secured, construction is set to begin in the second half of this year and is scheduled for completion in 2026.

"This investment in the Coronel plant reflects Peróxidos’ continuous and long-term commitment to bringing more innovative, sustainable and competitive solutions to the South American market and our mission to remain the preferred partner for our customers," comments Guilherme Silva, CEO of Peróxidos do Brasil.

Given its versatility and oxidizing properties, hydrogen peroxide (H2O2) is an essential input for a wide range of markets, such as the pulp and paper, aquaculture, electronics, packaging, and mining sectors. It stands out as an inherently sustainable product due to its molecular structure and environmentally compatible decomposition. When it breaks down, it forms water (H2O) and oxygen (O2) elements that naturally reintegrate into the environment without generating residues or byproducts. 

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.